Shenzhen Bioeasy Ownership

300942 Stock   9.88  0.74  6.97%   
Shenzhen Bioeasy Bio shows a total of 400.87 Million outstanding shares. Shenzhen Bioeasy Bio has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 74.88 % of Shenzhen Bioeasy outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Shenzhen Bioeasy in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Shenzhen Bioeasy, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
As of November 30, 2024, Dividends Paid is expected to decline to about 12.3 M. The current year's Net Income Applicable To Common Shares is expected to grow to about 285.6 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 318.2 M.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Bioeasy Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Shenzhen Stock Ownership Analysis

About 75.0% of the company shares are owned by insiders or employees . The book value of Shenzhen Bioeasy was presently reported as 2.13. The company recorded a loss per share of 0.2. Shenzhen Bioeasy Bio last dividend was issued on the 31st of May 2023. For more info on Shenzhen Bioeasy Biotechnology please contact the company at 86 755 2309 5742 or go to https://www.bioeasy.com.

Shenzhen Bioeasy Outstanding Bonds

Shenzhen Bioeasy issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Shenzhen Bioeasy Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Shenzhen bonds can be classified according to their maturity, which is the date when Shenzhen Bioeasy Biotechnology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Shenzhen Stock

Shenzhen Bioeasy financial ratios help investors to determine whether Shenzhen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shenzhen with respect to the benefits of owning Shenzhen Bioeasy security.